Biome Australia Quarterly Activities & Appendix 4C September 2023

● Biome reports record $2.74m sales revenue in Q1 FY24
● 59% gross margin maintained for Q1 FY24
● Same-store sales in pharmacy increased 25% vs. previous quarter
● Q1 FY24 cash receipts up 43% to $2.11m and accounts receivable increased
from $1.44m to $2.08m vs previous quarter (Q4 FY23)
● Biome expects first positive monthly EBITDA to occur during FY24
● Biome reaffirms it is sufficiently funded to execute its FY24 strategy
● Biome to launch into UK retail health and pharmacy in Q3 FY24